Please select a video from the list below.
Vascular and Endothelial Biomarkers in PAH
Dr. Ioana Preston reviews the results of 'Oral Treprostinil in Combination with Endothelin Receptor Antagonist and/or PDE-5 Inhibitor for the treatment of PAH (FREEDOM-C2)', presented at the 2016 CHEST Annual Meeting. The study objective was to determine whether in patients with PAH, vascular biomarkers correlate with 6-minute walk distance and NY Heart Association Functional Class.
Recent Video
Most Viewed
Specialties :                    Search :
RESPITE Study Results
RESPITE Study Results Views - 177
ICU Management of PH
ICU Management of PH Views - 113
Animal Models of PH
Animal Models of PH Views - 60
Holding Court in PAH
Holding Court in PAH Views - 1588
 CTEPH Basics
CTEPH Basics Views - 68
The INFORM Study
The INFORM Study Views - 399
Mental Health in PAH
Mental Health in PAH Views - 310